Up next

Autoplay

Clinical Development of Bumetanide in Autism - V. Crutel, PharmD PhD, Servier @Synchrony2020

0 Views • 08/17/25
Share
Side Effects
Side Effects
Subscribers
0

Veronique Crutel holds a Doctor of Pharmacy degree from the Free University of Brussels, Belgium and an advanced studies degree in Radiopharmaceuticals from the French National Institute for Nuclear Science and Technology. She received a PhD in CNS PET-Scan Radiopharmaceuticals from Paris XI University in 1996. She transitioned then to the pharmaceutical industry and after a few years working for a contract research organization, she joined Servier in 2000 as a project leader in the cardiology department. In 2004, she moved to the neuropsychiatric department, working on the development of compounds in depression and schizophrenia.

Since 2016, she has been leading as a project director a multidisciplinary team on the development of Bumetanide in Autism Spectrum Disorder (ASD).

This talk reviews the clinical development in ASD of bumetanide, as well as the regulatory requirements for the clinical development of medicinal products for the treatment of ASD. It was was part of The BRAIN Foundation Synchrony Symposium 2020

🎥 For more Synchrony 2020 talks and highlights: https://www.youtube.com/playli....st?list=PLDtO9h17tcW

🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

Synchrony https://synchronysymposium.com/ is the first and only international symposium on translational research in #autism, that brings together academia, #biotech, pharmaceutical companies and #venture partners from around the world with the mission to improve health and quality of life of people with #autismspectrumdisorder.

🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

The BRAIN Foundation https://brainfoundation.org/ is a 501c(3) non-profit. The founders of BRAIN envision a world where every child and adult on the autism spectrum is healthy, participates fully in education and employment, and has a better quality of life. It aims to catalyze research that results in evidence-based interventions for the disabilities associated with autism, and also results in better medical standard of care.

To accomplish this, it funds impactful research through #philanthropy and our network of partners in the venture, corporate, and grassroots community.

Show more
0 Comments sort Sort By

Up next

Autoplay